Humana Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Humana wird ein jährliches Gewinn- und Umsatzwachstum von 44.7% bzw. 4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 42.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.3% betragen.

Wichtige Informationen

44.7%

Wachstumsrate der Gewinne

42.7%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	33.9%
Wachstumsrate der Einnahmen	4.0%
Zukünftige Eigenkapitalrendite	9.3%
Analystenabdeckung	Low
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Oct 27

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Jul 22

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Recent updates

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Oct 31

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Oct 27

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Jul 22

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Gewinn- und Umsatzwachstumsprognosen

OM:HUM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	11,007	351	476	476	2
12/31/2025	10,569	240	439	406	2
12/31/2024	10,218	159	301	304	2
9/30/2024	10,014	124	739	909	N/A
6/30/2024	9,746	110	445	615	N/A
3/31/2024	9,621	146	484	654	N/A
12/31/2023	9,649	176	451	621	N/A
9/30/2023	9,685	228	316	508	N/A
6/30/2023	9,660	250	414	606	N/A
3/31/2023	9,491	232	414	606	N/A
12/31/2022	9,203	210	441	633	N/A
9/30/2022	8,869	183	490	520	N/A
6/30/2022	8,530	203	465	582	N/A
3/31/2022	8,347	242	481	598	N/A
12/31/2021	8,186	276	572	689	N/A
9/30/2021	8,000	293	593	813	N/A
6/30/2021	7,896	279	670	803	N/A
3/31/2021	7,825	272	603	736	N/A
12/31/2020	7,771	262	528	661	N/A
9/30/2020	7,750	230	543	613	N/A
6/30/2020	7,739	249	595	703	N/A
3/31/2020	7,670	197	434	662	N/A
12/31/2019	7,446	188	403	631	N/A
9/30/2019	7,247	222	327	556	N/A
6/30/2019	7,005	196	173	416	N/A
3/31/2019	6,774	245	265	425	N/A
12/31/2018	6,714	246	158	332	N/A
9/30/2018	6,600	228	252	396	N/A
6/30/2018	6,550	197	N/A	346	N/A
3/31/2018	6,541	199	N/A	216	N/A
12/31/2017	6,542	194	N/A	241	N/A
9/30/2017	6,635	195	N/A	-185	N/A
6/30/2017	6,684	241	N/A	-153	N/A
3/31/2017	6,540	226	N/A	-143	N/A
12/31/2016	6,362	148	N/A	-161	N/A
9/30/2016	6,140	139	N/A	255	N/A
6/30/2016	5,868	-11	N/A	202	N/A
3/31/2016	5,713	-53	N/A	233	N/A
12/31/2015	5,593	28	N/A	274	N/A
12/31/2014	5,065	38	N/A	156	N/A
12/31/2013	3,489	111	N/A	196	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HUMDas prognostizierte Gewinnwachstum (44.7% pro Jahr) liegt über der Sparquote (1.2%).

Ertrag vs. Markt: HUMDie Erträge des Unternehmens (44.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (15.1% pro Jahr).

Hohe Wachstumserträge: HUMEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: HUMDie Einnahmen des Unternehmens (4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (0.06% pro Jahr).

Hohe Wachstumseinnahmen: HUMDie Einnahmen des Unternehmens (4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: HUMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.3%).

Humana Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 14%

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Price target increased by 7.1% to kr37.50

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Recent updates

Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems

Consensus EPS estimates increase by 14%

kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 06, 2025

Humana AB Appoints Christoffer Herou as New CFO, Effective September 2, 2024

Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50

Second quarter 2024 earnings released: EPS: kr0.02 (vs kr0.75 in 2Q 2023)

New minor risk - Shareholder dilution

Fredrik Larsson, CFO of the Humana Group, to Leave His Position

Price target increased by 7.1% to kr37.50

Humana AB (Publ) Announces CEO Changes

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Investor sentiment improves as stock rises 15%

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

New major risk - Revenue and earnings growth

Consensus EPS estimates increase by 15%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 23%

Price target increased by 41% to kr23.50

New major risk - Share price stability

Investor sentiment improves as stock rises 42%

Humana AB (publ) Announces Board Appointments

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 16%

Does Humana (STO:HUM) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS exceeds analyst expectations

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Price target decreased by 23% to kr45.67

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Investor sentiment deteriorates as stock falls 50%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Price target decreased by 7.8% to kr59.33

Price target decreased to kr60.33

Humana AB (Publ) Announces Management Changes

Price target decreased to kr64.33

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Is Humana (STO:HUM) Using Too Much Debt?

Humana AB Announces Nomination Committee for 2023 AGM

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman of the Board recently bought kr38m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

Price target decreased to kr79.00

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr81.50

Full year 2021 earnings: Revenues in line with analyst expectations

Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

President & CEO recently bought kr180k worth of stock